Natco Pharma gets USFDA approval for Visakhapatnam facility

Hyderabad-based Natco Pharma Ltd on Tuesday said it has received the
final approval from the US health regulator for its first supplemental
abbreviated new drug application (sANDA) filed from its new drug
formulations facility at Visakhapatnam, Andhra Pradesh.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-usfda-approval-for-visakhapatnam-facility/articleshow/75423966.cms

Comments

Popular posts from this blog

Lupin, Aurobindo units recall products in US market

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

Data Analyst Jobs – Life Sciences Apply at Cognizant